Why the study?
Do elevated hs-CRP and HbA1c jointly predict major adverse cardiovascular events in patients with advanced atherosclerosis?
Do elevated hs-CRP and HbA1c jointly predict major adverse cardiovascular events in patients with advanced atherosclerosis?
Elevated hs-CRP and HbA1c jointly and independently predict future major adverse cardiovascular events in patients with advanced atherosclerosis.
No takes yet. Share an insight, caveat, or question.
May aid risk stratification in advanced atherosclerosis; hypothesis-generating for joint targeting trials.
Schillinger et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: